Adrian Grant Paez1,2, Suraj Rajan3,4, Alex Y Pantelyat3, Liana I Rosenthal3, Andreia Faria5, Xinyuan Miao2,6, Ted M Dawson3, Peter C. M. van Zijl1,2, Vidyulata Kamath4, and Jun Hua1,2
1Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, United States, 2F.M. Kirby Research Center, Kennedy Krieger Institute, Baltimore, MD, United States, 3Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States, 4Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States, 5Radiology and Radiological Science, Kennedy Krieger Institute, Baltimore, MD, United States, 6Johns Hopkins University School of Medicine, Baltimore, MD, United States
Synopsis
We demonstrate
significant structural abnormalities in the OB, primary and secondary olfactory
brain regions in early PD patients measured by high resolution MRI at 7T. The MRI measures showed significant correlations
with behavioral olfactory deficits in the participants.
Synopsis
We demonstrate
significant structural abnormalities in the OB, primary and secondary olfactory
brain regions in early PD patients measured by high resolution MRI at 7T. The MRI measures showed significant correlations
with behavioral olfactory deficits in the participants.Introduction
Parkinson’s disease
(PD) is a neurodegenerative disorder characterized by widespread impairments in
motor and cognitive/behavioral functions. Olfactory deficits in PD are
prevalent and reportedly present in up to 80-90% of sporadic PD cases(1-5). Such deficits can precede the onset of motor
symptoms(6-8), and may be one of the earliest symptoms in PD(9). Postmortem pathological studies have
demonstrated that Lewy bodies appear in the olfactory bulb (Braak Stage 1) before
spreading to lower brainstem nuclei and the amygdala (Braak stages 2–3), and
eventually substantia nigra and other midbrain regions (Braak stage 4: clinical
disease stage), when motor functions become clearly affected(10). Olfactory loss has been linked to α-synuclein
pathology, a major pathological hallmark of PD(11). Therefore, non-invasive and repeatable in vivo measures associated with
olfactory deficits may be excellent candidates as quantitative in vivo biomarkers in early PD for
tracking disease progression and evaluating treatment outcomes. In the human
olfactory system, odorants are received by olfactory sensory neurons in the
nasal epithelium,(12) which project first to glomeruli within the
olfactory bulbs (OB) and then to piriform cortex (PC), also known as the
primary olfactory cortex. Subsequently, neuronal networks in the orbitofrontal
cortex (OFC), insular cortex, hippocampus, amygdala, and hypothalamus are
involved to translate external odor information into behavioral responses(13). These regions are often referred to as
secondary olfactory regions. Structural changes in the OB, PC and secondary
olfactory regions have been reported in PD. In this study, high resolution
structural MRI scans were performed in early PD patients and matched controls
to systemically investigate structural abnormalities in the primary and secondary
olfactory regions. The experiments were conducted on ultra-high magnetic field
(7.0 Tesla or 7T) human MRI scanner to enhance the sensitivity. The
relationship between MRI and behavioral olfactory measures was investigated. Methods
All MRI scans were performed on a 7T
Philips MRI scanner. A cohort of 15 PD patients, and 15 healthy controls
matched in age, sex, and education level were recruited for the study (Table 1). The University of
Pennsylvania Smell Identification Test (UPSIT) (14,15) was administrated to
all participants to assess their behavioral olfactory functions. The following
scans were performed for each participant: 1) MPRAGE MRI (16,17) (voxel=1mm isotropic, TR/TE/TI=5ms/1.81ms/563ms);
2) T2-weighted scan (voxel=0.5mm isotropic, TR/TE=5000ms/58ms). Due to its
small size and unique contrast, the OB was manually traced on the T2-weighted
images. Thirteen additional regions of interest (ROI) in the cortex and
subcortex were manually identified and segmented on the MPRAGE images. Figure 1 shows an example of the
segmentation from one participant. Volumes of individual ROI were calculated
using a custom Matlab script. Two-sample t-tests were performed to examine
group difference in the volumes of individual ROI. Age and sex were accounted for
as covariates. Correlations between volumes of ROIs and UPSIT scores were
assessed with multiple regression with age and sex as covariates. Multiple
comparisons were corrected with the false-discovery rate (adjusted P <
0.05). Results
The
behavioral olfactory test (UPSIT) scores were significantly lower in early PD
patients compared to controls, indicating impaired olfactory function in PD
patients. Figure 2 shows the group
comparison results of the measured volumes of the OB, primary (piriform cortex)
and secondary olfactory regions in early PD patients and controls. The volume
of OB did not show significant difference between PD and controls. The volumes
of the primary olfactory (piriform) cortex were significantly lower in early PD
patients. In contrast, the volumes of insula, thalamus, caudate and cingulate
cortex were significantly higher in PD patients. Figure 3 shows the correlation analysis between region volumes and
the UPSIT scores, which revealed significant positive correlations in the OB,
piriform cortex and amygdala, and significant negative correlations in the
insula, caudate and cingulate cortex.
Discussion & Conclusion
We demonstrate
significant structural abnormalities in the OB, primary and secondary olfactory
brain regions in early PD patients measured by high resolution MRI at 7T. The MRI measures showed significant correlations
with behavioral olfactory deficits in the participants. Acknowledgements
No acknowledgement found.References
(1)Doty, RL, et al. Neurology 1988;38:1237.
(2)Markopoulou, K, et al. Neurology 1997;49:1262.
(3)Berendse, HW, et al. Ann Neurol 2001;50:34.
(4)Doty, RL Neurobiol
Dis 2012;46:527.
(5)Ansari, KA, et al. J Chronic Dis 1975;28:493.
(6)Montgomery, EB, Jr., et al. Neurology 1999;52:757.
(7)Ponsen, MM, et al. Ann Neurol 2004;56:173.
(8)Ross, GW, et al. Ann Neurol 2008;63:167.
(9)Hawkes, CH, et al. Parkinsonism Relat Disord
2010;16:79.
(10)Braak, H, et al. Neurobiol Aging 2003;24:197.
(11)Doty, RL Nat Rev
Neurol 2012;8:329.
(12)Buck, L, et al. Cell 1991;65:175.
(13)Doty, RL. (2015) Handbook of olfaction and gustation.
Hoboken, New Jersey: Wiley Blackwell
(14)Doty, RL, et al. Physiol Behav 1984;32:489.
(15)Doty, RL, et al. Perception \& Psychophysics
1989;45:381.
(16)Marques, JP, et al. Neuroimage 2010;49:1271.
(17)Van de Moortele, PF, et al. Neuroimage 2009;46:432.